Genesco (NYSE: GCO) awards director 3,905 restricted stock shares

Rhea-AI Filing Summary

SANDFORT GREGORY A reported acquisition or exercise transactions in this Form 4 filing.

Genesco Inc. reported a Form 4 transaction for director Gregory A. Sandfort, who received a grant of 3,905 shares of Common Stock as restricted stock on 2026-07-24 under the Fourth Amended and Restated 2020 Equity Incentive Plan. The award was priced at $0.00 per share, increasing his direct holdings to 22,535 shares.

Insider Trade Summary

Net Buyer: 3,905 shares

Net Buy 1 txn

Insider SANDFORT GREGORY A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	3,905	$0.00	$0.00

Holdings After Transaction: Common Stock — 22,535 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

Key Figures

Restricted stock grant: 3,905 shares Grant price: $0.0000 per share Post-transaction holdings: 22,535 shares +1 more

4 metrics

Restricted stock grant 3,905 shares Common Stock granted to director Gregory A. Sandfort on 2026-07-24

Grant price $0.0000 per share Price per share for the restricted stock grant

Post-transaction holdings 22,535 shares Total Genesco Common Stock directly owned by Sandfort after the grant

Transaction date 2026-07-24 Date of the reported Form 4 equity award

Key Terms

restricted stock, Fourth Amended and Restated 2020 Equity Incentive Plan

2 terms

restricted stock financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Fourth Amended and Restated 2020 Equity Incentive Plan financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/24/2026 - 04:03 PM Accepted by SEC EDGAR 07/24/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What insider transaction did GENESCO INC (GCO) report in this Form 4?

GENESCO INC reported that director Gregory A. Sandfort received a grant of restricted stock. The award covered 3,905 shares of Common Stock under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan on 2026-07-24.

How many GENESCO INC (GCO) shares did Gregory A. Sandfort acquire?

Gregory A. Sandfort acquired 3,905 shares of Genesco Common Stock as a restricted stock grant. The grant was recorded at $0.00 per share and represents an equity incentive award rather than an open-market purchase.

What are Gregory A. Sandfort’s total GENESCO INC (GCO) holdings after the grant?

Following the reported transaction, Gregory A. Sandfort directly owns 22,535 shares of Genesco Common Stock. This total reflects his position after receiving the 3,905-share restricted stock grant disclosed in the Form 4 filing.

Was the GENESCO INC (GCO) stock grant made under an equity incentive plan?

Yes. The filing states the award is a grant of restricted stock under Genesco’s Fourth Amended and Restated 2020 Equity Incentive Plan, indicating it is part of the company’s structured equity-based compensation program.

Was the GENESCO INC (GCO) Form 4 transaction under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked, and there is no footnote stating the grant occurred under a Rule 10b5-1 trading plan or similar pre-arranged program.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SANDFORT GREGORY A

(Last) (First) (Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE TENNESSEE 37214

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2026		A		3,905(1)	A	$0.00	22,535	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

	Scott E. Becker, Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)